Menu ×


Lipase Reagent Market Analysis by Type (Turbidity Method, and Colorimetric Method);by Application (Hospitals, Clinics,and Others);and by Indication (Pancreatic Disorders, Cancer, and Cystic Fibrosis) – Global Supply & Demand Analysis & Opportunity Outlook 2022-2031

  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More


  • August, 2021: AzuRxannounced a positive resultof MS1819 during phase 2 trials, by assessing MS1819 along with porcine-derived pancreatic enzyme replacement therapy for treating severe exocrine pancreatic insufficiency in patients with cystic fibrosis.
  • April, 2019:DiaSysDiagnostic Systems GmHbannounced the development of Lipase DC FS, a state-of-the-art direct colorimetric assay, withimproved stability for Pancreatic Diagnosis.


Global Lipase Reagent Market Size, Forecast, and Trend Highlights Over 2022 - 2031


The global lipase reagentmarket is estimated to garner a revenue of USD 1160 million by the end of 2031 by growing at a CAGR of ~7% over the forecast period, i.e., 2022 – 2031. Further, the market generated a revenue of USD 590million in the year 2021. The growth of the market can be attributed to the increasing number of patients who are suffering from different diseases that require lipase analysis.The lipase testing reagents act as indicators to study the presence of pancreas-related disorders and other gastric problems. The rise in widespread demand for lipase testingreagents on account of indigestion, acute and chronic pancreatic disorders, gastroesophageal reflux disease (GERD), and other intestinal disorders is expected to drive the market growth during the forecast period. The incidence of acute pancreatitis raised from 28per 100,000 population in 1999 to 36 per every 100,000 population in 2010.


Get more information on this report: Request Sample PDF

Other major factors contributing to the growth of the market include the increase in diseases like vitamin deficiency, dehydration, malnutrition, high gastric acids, and persistent diarrhea. As per the Centers for Disease Control and Prevention, the number of adults diagnosed with ulcers was about 14.8 million in 2018.

Besides, the demand for lipase testing reagents market is propelling as children with cystic fibrosis (CF) or Schwachman-Diamond Syndrome (SDS) diagnosis increase. Lipase levels are high in patients with cystic fibrosis. According to the World Gastroenterology Organization, out of 100%, 49% of females and 36.6% of males have the most common disorders like constipation, diarrhea, IBS, proctalgia fungax, and dyspepsia at rates of 11.7%, 4.7%, 4.1%, 5.9%, and 7.2% respectively.

Global Lipase Reagent Market: Growth Drivers and Challenges

Growth Drivers

  • Increasing Gastrointestinal Issues in Children- Globally, 1.7 billion childhood diarrhealdisease caseswere reportedevery year, as per WHO.Lipase reagent is used as a treatment for gastrointestinal issues. As a result, the growing prevalence of stomach issues is estimated to boost the market growth.

  • Rising Concern for DiagnosisThe primary diagnosis at office visits for all digestive diseases wasstated to be 36.6 million in the year 2010 in the U.S.
  • Government Initiatives in the Healthcare SectorThe Universal Health Coverage progress rate is projected to cover health services to 290 million by 2023, compared to the baseline value of 2018 leaving a difference of 710 million to reach the target.
  • Poor Lifestyle and Nutritional DeficiencyAs per the Food and Agriculture Organization of the United Nations, it is estimated that between720 to 811 million individualsfaced hunger worldwide in 2020.
  • Lack of Sanitation Knowledge and the Unhygienic EnvironmentAs of 2021 among 3.6 billion people, only 1.9 billion people are living with basic sanitation services and 494 million go for open defecation.Moreover, the growth in population is also leading to higher demand for sanitation services, which is further anticipated to boost the market growth.The world population raised from about 1 billion in 1800 to 7.9 billion in 2019.


  • Lack of Proper Healthcare System in Low-Income Regions
  • Less Awareness of the Diagnosis and Gastric Issues
  • High TreatmentCost– In 2019, one-fourth,about 26% of U.S adults reported that they had a problem paying medical bills, 2018.

The global lipase reagent market is segmented and analyzed for demand and supply by application intohospitals, clinics& others, out of which, the hospital segment is anticipated to hold the largest market size by the end of 2031. The market is estimated to grow on account of expanding healthcare sector and advancements in technology within the medical sector for diagnostics and therapeutics.As per estimations of the Organization for Economic Co-operation and Development (OECD), health expenditure raised by 5% from 8.8% GDP in 2019 to 9.7% GDP in 2020 across OECD countries.

Major Macro-Economic Indicators Impacting the Market Growth


According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5,355.79, which grew from USD 3,515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Lipase Reagent Market Regional Synopsis

Regionally, the global lipase reagentmarket is studied into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. Amongst these markets, the market in North America region is projected to hold the largest market share by the end of 2031on the back of increasing concern among people about complications related to the gastrointestinal tract. Among440 million non-cancer medical conditions, over22 million acute digestive conditions with 11 million gastroenteritis and 6 million indigestion cases are reported.

Besides, the North America region is having good infrastructure and more hospitals propelling the growth of theglobal lipase reagent market during the forecast period. According to the American Hospital Association,the total number of all hospitals in the North America region is 6,000 with staffed beds of 920,000 in 2022. Also, the regional government policies towards the public health care programs attribute to the growth of the market.


The global lipase reagentmarket is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation                   

Our in-depth analysis of the global lipase reagentmarket includes the following segments:

By Type


  • Turbidimetry method
  • Colorimetric method

By Application

  • Hospitals
  • Clinics
  • Others

By Indication

  • Pancreatic Disorders
  • Cancer
  • Cystic Fibrosis

Top Featured Companies Dominating the Global Lipase Reagent Market

    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • DiaSys Diagnostic Systems GmbH
  • Sunson Industry Group Co., Ltd
  • Randox Laboratories Ltd.
  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • CompareNetworks, Inc.
  • VitroScient
  • Merck Group
  • Sisco Research LaboratoriesPvt. Ltd.
  • BioSystems SA


Related Reports

Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved